1. Home
  2. CGEN vs MSGY Comparison

CGEN vs MSGY Comparison

Compare CGEN & MSGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • MSGY
  • Stock Information
  • Founded
  • CGEN 1993
  • MSGY 2018
  • Country
  • CGEN Israel
  • MSGY Hong Kong
  • Employees
  • CGEN N/A
  • MSGY N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • MSGY
  • Sector
  • CGEN Health Care
  • MSGY
  • Exchange
  • CGEN Nasdaq
  • MSGY Nasdaq
  • Market Cap
  • CGEN 167.4M
  • MSGY 169.3M
  • IPO Year
  • CGEN 2000
  • MSGY 2025
  • Fundamental
  • Price
  • CGEN $1.45
  • MSGY $13.48
  • Analyst Decision
  • CGEN
  • MSGY
  • Analyst Count
  • CGEN 0
  • MSGY 0
  • Target Price
  • CGEN N/A
  • MSGY N/A
  • AVG Volume (30 Days)
  • CGEN 206.7K
  • MSGY 145.2K
  • Earning Date
  • CGEN 08-06-2025
  • MSGY 01-01-0001
  • Dividend Yield
  • CGEN N/A
  • MSGY N/A
  • EPS Growth
  • CGEN N/A
  • MSGY N/A
  • EPS
  • CGEN N/A
  • MSGY 0.10
  • Revenue
  • CGEN $22,144,000.00
  • MSGY $23,318,482.00
  • Revenue This Year
  • CGEN N/A
  • MSGY N/A
  • Revenue Next Year
  • CGEN $159.40
  • MSGY N/A
  • P/E Ratio
  • CGEN N/A
  • MSGY $133.94
  • Revenue Growth
  • CGEN N/A
  • MSGY 13.04
  • 52 Week Low
  • CGEN $1.13
  • MSGY $3.83
  • 52 Week High
  • CGEN $2.66
  • MSGY $18.68
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 48.38
  • MSGY N/A
  • Support Level
  • CGEN $1.39
  • MSGY N/A
  • Resistance Level
  • CGEN $1.46
  • MSGY N/A
  • Average True Range (ATR)
  • CGEN 0.06
  • MSGY 0.00
  • MACD
  • CGEN 0.00
  • MSGY 0.00
  • Stochastic Oscillator
  • CGEN 52.63
  • MSGY 0.00

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About MSGY Masonglory Limited Ordinary Shares

Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.

Share on Social Networks: